• Japan REITs Favored, May Gain 25%, Freeze Says
  • Billionaire Frost Props Up Prolor Bid With Stock Buys
  • Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
  • U.S. Stock Options With Biggest Changes in Implied Volatility
  • Canada Supreme Court Won’t Hear Eli Lilly Zyprexa Appeal
  • ThromboGenics Reports Jetrea Sales as Drug Fails Mid-Stage Study
  • Swiss Stocks Drop as Zurich Insurance Retreats on Profit
  • BlackRock Has Alternative to Money Funds: Credit Markets
  • DBV in Advanced Talks for U.S. Peanut Drug Partnership, CEO Says
  • Golden Parachutes Face Clampdown in EU Law on Executive Pay
  • Lundbeck Jumps as Depression Drug Gets Praise: Copenhagen Mover
  • Roche Experimental Leukemia Drug Helps Shrink Tumors
  • Algeta Surges to Record After Prostate Cancer Drug Approval
  • AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
  • SAC Owes $549 Million for Elan Trades, Investors Say
« Previous 1 2 3 4 5 Next »